Regeneron Pharmaceuticals said the company will vigorously defend federal charges of being involved in a kickback scheme to bolster sales of the blockbuster macular degeneration drug Eylea.
https://www.pharmalive.com/wp-content/uploads/2020/06/U.S.-Government-Alleges-Regeneron-Used-Kickbacks-to-Boost-Eylea-Sales-BioSpace-6-25-20.jpeg350625BioSpacehttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngBioSpace2020-06-25 11:57:452020-07-07 18:08:52U.S. Government Alleges Regeneron Used Kickbacks to Boost Eylea Sales